091990.KQ

N/A

Celltrion Healthcare Co., Ltd. — PEG Ratio Analysis

—

PEG Ratio

Negative EPS growth — PEG not meaningful when earnings are declining

—

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$63000.00

TTM EPS

$274.48

P/E Ratio

229.52

Growth Rate

-2.4%

5-Year EPS CAGR

Sector

Healthcare

Biotechnology

Calculated

6/17/2026

9:12:58 AM

PEG Ratio Unavailable

Negative Growth — PEG not meaningful

Peer Comparison

Sample Size

5 peers

Industry Median PEG

1.67

25th Percentile

1.57

75th Percentile

4.34

Symbol	Company	PEG	P/E	Growth	vs 091990.KQ
207940.KS	Samsung Biologics Co.,Ltd.	0.56	33.8	60.7%	—
035420.KS	NAVER Corporation	1.57	21.4	13.6%	—
035720.KS	Kakao Corp.	1.67	40.2	24.1%	—
068760.KQ	Celltrion Pharm, Inc.	4.34	52.3	12.0%	—
068270.KS	Celltrion, Inc.	6.38	28.9	4.5%	—

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.